Patent Assignment
Reel/Frame 039050/0882
SECURITY AGREEMENT
Recorded: 2016-06-16
Received: 2016-06-16
Pages: 7
Assignor
AEGERION PHARMACEUTICALS, INC.
Executed: 2016-06-14
Assignee
SILICON VALLEY BANK
3003 TASMAN DRIVE, SANTA CLARA, CA, 95054, UNITED STATES
Covered Applications
(5)
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
App. No. 14/837,705
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
App. No. 14/800,537
→
A CHIMERIC LEPTIN POLYPEPTIDE AND METHOD OF USING THE SAME
App. No. 14/703,523
→
COMPOUND IMPURITIES AND METHODS OF DETECTING SAME
App. No. 62/154,906
→
ENGINEERED POYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
App. No. 14/129,793
→